Regional and systemic therapies for advanced golorectal carcinoma: randomized clinical trial results

INIS

• uracils 100%
• leucovorin 36%
• infusion 31%
• cancer 26%
• doses 21%
• therapy 15%
• toxicity 15%
• patients 10%
• diseases 10%
• comparative evaluations 10%
• fudr 10%
• data 5%
• drugs 5%
• clinical trials 5%
• liver 5%
• investigations 5%
• cooperatives 5%
• leukemia 5%
• spectra 5%
• interferon 5%
• carcinomas 5%
• aspartic acid 5%
• dexamethasone 5%

Pharmacology, Toxicology and Pharmaceutical Science

• Fluorouracil 100%
• Folinic Acid 36%
• Colorectal Cancer 15%
• Survival 15%
• Diseases 10%
• Toxicity 10%
• Malignant Neoplasm 10%
• Overall Survival 5%
• Interferon 5%
• Irinotecan 5%
• Dexamethasone 5%
• Aspartic Acid 5%
• Leukemia 5%
• Capecitabine 5%
• Carcinoma 5%
• Randomized Clinical Trial 5%
• Phase II Trials 5%
• Oxaliplatin 5%
• 5 Ethynyluracil 5%
• Fluoropyrimidine 5%
• UFT 5%
• Thymidylate Synthase Inhibitor 5%
• Drug 5%
• Clinical Trial Results 5%